stone disease

Stone retrieval device shows high versatility, efficacyResults from bench studies favor a new open-faced stone retrieval device (Dakota, Boston Scientific) for having greater versatility, efficacy, and durability compared with a competing product, and the in vitro performance of the new instrument is consistent with early clinical experience, says Roger L. Sur, MD.
Use new data to inform unique patient group"Increasingly, urologists are faced with patients who cannot safely discontinue anticoagulation or antiplatelet medications, even in the face of an impending surgical procedure. This is a trend that is likely to continue into the foreseeable future," writes Brian R. Matlaga, MD, MPH.
Study: Statin users less likely to develop kidney stonesA large new study provides more evidence that cholesterol drugs may lower kidney stone formation.
Discordance seen with reporting of food oxalate valuesA study evaluating the oxalate content of foods as reported by two reputable sources shows discordance.
New study supports MET for larger ureteric stonesA recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Study: Patients taking aspirin can safely undergo PCNLPercutaneous nephrolithotomy in the presence of aspirin appears both effective and safe. In a retrospective review of almost 300 PCNL cases, postoperative hemorrhage was uncommon in patients who continued aspirin preoperatively, said Brandon Otto, MD, at the AUA annual meeting in San Diego.
Persistent decline in renal function seen after first stone case“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.